Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

SHSE:600613 Stok Raporu

Piyasa değeri: CN¥3.5b

Shanghai Shenqi Pharmaceutical Investment Management Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Feng Bin

İcra Kurulu Başkanı

CN¥480.3k

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi13.4yrs
CEO sahipliğin/a
Yönetim ortalama görev süresiVeri yok
Yönetim Kurulu ortalama görev süresiVeri yok

Son yönetim güncellemeleri

Recent updates

There May Be Reason For Hope In Shanghai Shenqi Pharmaceutical Investment Management's (SHSE:600613) Disappointing Earnings

Nov 06
There May Be Reason For Hope In Shanghai Shenqi Pharmaceutical Investment Management's (SHSE:600613) Disappointing Earnings

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.'s (SHSE:600613) 26% Share Price Surge Not Quite Adding Up

Oct 21
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.'s (SHSE:600613) 26% Share Price Surge Not Quite Adding Up

Why Shanghai Shenqi Pharmaceutical Investment Management's (SHSE:600613) Earnings Are Better Than They Seem

May 06
Why Shanghai Shenqi Pharmaceutical Investment Management's (SHSE:600613) Earnings Are Better Than They Seem

Investor Optimism Abounds Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE:600613) But Growth Is Lacking

Apr 17
Investor Optimism Abounds Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE:600613) But Growth Is Lacking

CEO

Feng Bin (52 yo)

13.4yrs

Görev süresi

CN¥480,300

Tazminat

Mr. Feng Bin is a Director of Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. (formerly known as Shanghai Wingsung Investment Management Co., Ltd.) and serves as its General Manager since Jun...